Viking Therapeutics, Inc. — Director's Dealing 2021

Jan 6, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Viking Therapeutics, Inc. (VKTX)
CIK: 0001607678
Period of Report: 2021-01-04

Reporting Person: ZANTE GREG (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.00001 per share	21896	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.68	2030-03-31	Common Stock (17000)		Direct
Stock Option (Right to Buy)	$7.77	2030-01-03	Common Stock (51000)		Direct
Stock Option (Right to Buy)	$7.69	2029-07-31	Common Stock (42000)		Direct
Stock Option (Right to Buy)	$8.52	2029-01-15	Common Stock (32000)		Direct
Stock Option (Right to Buy)	$13.07	2028-08-31	Common Stock (7500)		Direct
Stock Option (Right to Buy)	$4.12	2028-04-30	Common Stock (7500)		Direct
Stock Option (Right to Buy)	$4.65	2028-01-19	Common Stock (12250)		Direct

Footnotes

F1: Includes (a) 2,334 shares subject to a restricted stock unit award ("RSU") of common stock that was granted on January 19, 2018 under the Issuer's
2014 Equity Incentive Plan, of which one-third of the original 7,000 shares subject to the RSU vested or shall vest on each one year anniversary of the
grant date of the award; and (b) 15,111 shares subject to an RSU of common stock that was granted on January 3, 2020 under the Issuer's 2014 Equity Incentive Plan, of which one-third of the original 22,666 shares subject to the RSU vested or shall vest on each one year anniversary of the grant
date of the award.

F2: 25% of the shares subject to the option will vest on each one year anniversary of the grant date of March 31, 2020.

F3: 25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date of January 3, 2020.

F4: One-third of the shares subject to the option vested or will vest on each one year anniversary of the grant date of July 31, 2019.

F5: 25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date of January 15, 2019.

F6: One-third of the shares subject to the option vested on the grant date and one-third of the shares subject to the option vested on each one year
anniversary of the grant date of August 31, 2018.

F7: 25% of the original 30,000 shares subject to the option vested on the grant date and 25% of the original 30,000 shares subject to the option vested or will vest on each one year anniversary of the grant date of April 30, 2018.

F8: 25% of the original 24,500 shares subject to the option vested or will vest on each one year anniversary of the grant date of January 19, 2018.